GI Surgery – Bariatric Surgery | Links Medicus Content Curation & Alerts in Medicine

10-year follow-up of the SLEEVEPASS RCT: both sleeve and gastric bypass resulted in good #weightloss. Reflux was more prevalent after sleeve. The incidence of #Barrettesophagus was much lower than in previous trials, and similar after both procedures. https://t.co/zRLzB6Nf7a

— JAMA Surgery (@JAMASurgery) June 22, 2022

Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study.

21 Jun, 2022 | 10:44h | UTC

Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study – BJS Open

Commentary on Twitter

#Bariatric surgery improves metabolic health of patients, but what are the risks if they have had MI before surgery?

National dataset matched 16000 pts🇸🇪
Heart dis assoc w/🔼 cardiac events post op, plus 🔼risk of SBO and stricture.#SoMe4Surgery https://t.co/iHsZiHIgdG pic.twitter.com/v2SXMpcZd3

— BJS Open (@BjsOpen) June 17, 2022

#ADA2022 – Retrospective Cohort Study: Association of bariatric surgery with cancer risk and mortality in adults with obesity.

6 Jun, 2022 | 11:54h | UTC

Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity – JAMA (free for a limited period)

Editorial: Bariatric Surgery and Cancer Risk – JAMA (free for a limited period)

News Release: Weight loss with bariatric surgery cuts the risk of developing cancer and death from cancer – Cleveland Clinic

Commentaries on Twitter

In this study, among adults with #obesity, #bariatricsurgery compared with no surgery was associated with a significantly lower incidence of obesity-associated #cancer and cancer-related mortality. https://t.co/x2gz3RUdra

— JAMA (@JAMA_current) June 3, 2022

Retrospective cohort presented at the @AmDiabetesAssn: incidence rate of 3.0 events vs 4.6 events per 1,000 person-years, resp, & a 32% reduced risk for developing obesity-related cancer following weight loss via surgery. @ClevelandClinic

https://t.co/6jLDmhgJbR @JAMA_current

— Karl Nadolsky (@DrKarlNadolsky) June 4, 2022

ERAS Guidelines for perioperative care in elective abdominal and pelvic surgery at primary and secondary hospitals in low–middle-income countries.

1 Jun, 2022 | 12:08h | UTC

Guidelines for Perioperative Care in Elective Abdominal and Pelvic Surgery at Primary and Secondary Hospitals in Low–Middle-Income Countries (LMIC’s): Enhanced Recovery After Surgery (ERAS) Society Recommendation – World Journal of Surgery

Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

M-A: Endoscopic bariatric and metabolic therapies and their effects on metabolic syndrome and non-alcoholic fatty liver disease.

27 May, 2022 | 11:31h | UTC

Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease – A Systematic Review and Meta-Analysis – Frontiers in Medicine

M-A: Bariatric surgery and cardiovascular disease.

6 Mar, 2022 | 23:34h | UTC

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis – European Heart Journal

Cohort study: In patients who underwent bariatric surgery, those submitted to gastric bypass were slightly more likely to remain free of obesity-related medications during follow-up compared with those who underwent sleeve gastrectomy.

18 Jan, 2022 | 09:31h | UTC

Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass – JAMA Surgery (link to abstract – $ for full-text)

Commentary: Gastric Bypass Tied to Modest Shift in Need for Comorbidity Meds – MedPage Today (free registration required)

Commentary on Twitter

Among patients taking medications for obesity-related conditions before bariatric surgery, gastric bypass and sleeve gastrectomy both had high rates of medication discontinuation after surgery, however gastric bypass was slightly more effective. https://t.co/JrIaYk9dZT pic.twitter.com/BAbaGINCpb

— JAMA Surgery (@JAMASurgery) January 12, 2022

ERAS Guidelines for perioperative care in bariatric surgery.

16 Jan, 2022 | 23:21h | UTC

Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update – World Journal of Surgery

Commentary on Twitter

#VisualAbstract ➡️ Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update@Jasosamd @iss_sic
🆓🔗https://t.co/HknWwLUjCZ pic.twitter.com/amhszadwup

— WJS (@WorldJSurg) January 5, 2022

Cohort Study: Patients who achieved weight loss through bariatric surgery may have lower risk for severe Covid-19 compared to patients who did not have surgical intervention for their obesity.

14 Jan, 2022 | 08:32h | UTC

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection – JAMA Surgery

Commentaries:

Is COVID-19 the Newest Comorbidity of Obesity Mitigated by Bariatric Surgery? – JAMA Surgery

Can weight loss help protect against Covid-19? – CNN

RCT: Adjustable intragastric balloon resulted in significant weight loss at 32 weeks, but intolerance caused early removal of the device in 17% of patients, and device-related serious adverse events were observed in 4% of patients.

17 Nov, 2021 | 08:26h | UTC

Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial – The Lancet (link to abstract – $ for full-text)

Commentary on Twitter

In this trial, when an adjustable intragastric balloon was combined with lifestyle modification in adults with obesity, significant weight loss was achieved and maintained for 6 months following device removal. https://t.co/jg7z5ldeC7 #GITwitter pic.twitter.com/Pi9PVAeWzo

— The Lancet (@TheLancet) November 16, 2021

Cohort study: In patients with nonalcoholic steatohepatitis and obesity, bariatric surgery was associated with lower risk of incident major adverse liver outcomes and major adverse cardiovascular events.

12 Nov, 2021 | 10:24h | UTC

Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis – JAMA (free for a limited period)

Editorial: Bariatric Surgery as a Strategy for Improving Outcomes in Nonalcoholic Steatohepatitis – JAMA (free for a limited period)

Commentary on Twitter

Study found, among patients with nonalcoholic steatohepatitis and obesity, bariatric surgery, vs nonsurgical management, was associated with a significantly lower risk of incident major adverse liver outcomes and major adverse cardiovascular events https://t.co/Ps23yfjncq

— JAMA (@JAMA_current) November 11, 2021

Stay Updated in Your Specialty